PRMT5 and astrocytoma (excluding glioblastoma): Suva et al. found that IDH-mutant WHO G4 astrocytomas exhibit lower levels of PRMT5 expression compared to IDH-wildtype glioblastoma, suggesting that PRMT5 may be influenced by IDH mutation [21].